These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9356162)

  • 1. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity.
    Heinrichs RW; Ruttan L; Zakzanis KK; Case D
    Brain Cogn; 1997 Nov; 35(2):207-24. PubMed ID: 9356162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
    Sota TL; Heinrichs RW
    Compr Psychiatry; 2004; 45(5):415-21. PubMed ID: 15332206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and validity of memory-based subtypes of schizophrenia.
    Vaz SM; Heinrichs RW
    J Int Neuropsychol Soc; 2006 Nov; 12(6):782-91. PubMed ID: 17064442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of clustering solutions for cognitive heterogeneity in schizophrenia.
    Goldstein G; Allen DN; Seaton BE
    J Int Neuropsychol Soc; 1998 Jul; 4(4):353-62. PubMed ID: 9656609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study.
    Kurtz MM; Moberg PJ; Ragland JD; Gur RC; Gur RE
    Schizophr Bull; 2005 Jan; 31(1):167-74. PubMed ID: 15888434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
    Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of schizophrenia and neurocognitive test performance.
    Shean G; Burnett T; Eckman FS
    J Clin Psychol; 2002 Jul; 58(7):723-31. PubMed ID: 12205713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatological and cognitive predictors of insight in chronic schizophrenia.
    Nakano H; Terao T; Iwata N; Hasako R; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):65-72. PubMed ID: 15261706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognition in first-episode schizophrenia: a meta-analytic review.
    Mesholam-Gately RI; Giuliano AJ; Goff KP; Faraone SV; Seidman LJ
    Neuropsychology; 2009 May; 23(3):315-36. PubMed ID: 19413446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest stability of neuropsychological testing and individual differences in variability in schizophrenia outpatients.
    Conway Greig T; Nicholls SS; Wexler BE; Bell MD
    Psychiatry Res; 2004 Dec; 129(3):241-7. PubMed ID: 15661317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals.
    Pietrzak RH; Snyder PJ; Jackson CE; Olver J; Norman T; Piskulic D; Maruff P
    Hum Psychopharmacol; 2009 Mar; 24(2):113-21. PubMed ID: 19090506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia.
    Halari R; Mehrotra R; Sharma T; Ng V; Kumari V
    Psychiatry Res; 2006 Feb; 141(2):129-39. PubMed ID: 16427141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of patients with schizophrenia on the Wisconsin Card Sorting Test (WCST).
    Everett J; Lavoie K; Gagnon JF; Gosselin N
    J Psychiatry Neurosci; 2001 Mar; 26(2):123-30. PubMed ID: 11291529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological subtyping of schizophrenia.
    Ilonen T; Taiminen T; Karlsson H; Lauerma H; Leinonen KM; Wallenius E; Salokangas RK
    Psychiatry Res; 2004 Dec; 129(2):191-9. PubMed ID: 15590046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared cognitive processes underlying performance on the Wisconsin Card Sorting Test and the Stroop Test in patients with schizophrenia: a measurement artifact?
    Kosmidis MH; Bozikas VP; Zafiri M; Karavatos A
    Neurosci Lett; 2006 Dec; 409(3):234-8. PubMed ID: 17030094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.